Chiropractors in La Grange, KY Accepting Medicare
7 Chiropractors found. Showing 1 - 7
 Dr. Deborah Clara Wickham, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 301 E Jefferson St, La Grange, KY 40031 Phone: 502-758-2269 |
Dr. Rebecca Jean Shelburne, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4201 W Highway 146, La Grange, KY 40031 Phone: 502-265-0184 Fax: 502-222-8216 |
 Dawson Spine & Sport Chiropractic, Inc Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 410 W Jefferson St, La Grange, KY 40031 Phone: 502-465-0055 Fax: 502-265-1215 |
 Christopher W Meadows, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 301 S 1st Ave, La Grange, KY 40031 Phone: 502-222-0000 Fax: 507-974-0570 |
Back To Life Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 4201 W Highway 146, La Grange, KY 40031 Phone: 502-241-1122 Fax: 502-470-7347 |
Preble Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 W Madison St, La Grange, KY 40031 Phone: 502-222-7611 |
Dr. William Ray Reed, D.C., PH.D. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 301 E Jefferson Street, La Grange, KY 40031 Phone: 502-222-1897 |
News Archive
NeuroVista technology shows promise in detecting and predicting seizures
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
Pre-clinical data of BiTE antibody technology published in PNAS
Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.
Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
Teenagers being bombarded by alchohol advertising
Alcohol advertising on television, and youth exposure to it, grew substantially in 2002 from 2001, and although new industry marketing codes were announced in 2003, they will still allow for substantial youth overexposure to alcohol ads, according to a study released today by the Center on Alcohol Marketing and Youth at Georgetown University.
› Verified 5 days ago
Speech-Language Pathologists
Occupational Therapists
Physical Therapists
Chiropractors
Optometrists